BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1333423)

  • 21. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis.
    Piepponen T; Blomqvist K; Brandt H; Havu V; Hollmen A; Kohtamäki K; Lehtonen L; Turjanmaa K
    J Antimicrob Chemother; 1992 Feb; 29(2):195-205. PubMed ID: 1324238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
    Engelhard D; Or R; Naparstek E; Leibovici V
    Bone Marrow Transplant; 1988 Sep; 3(5):517-9. PubMed ID: 2847846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermatophyte infections in children.
    Howard RM; Frieden IJ
    Adv Pediatr Infect Dis; 1999; 14():73-107. PubMed ID: 10079850
    [No Abstract]   [Full Text] [Related]  

  • 24. Itraconazole in the treatment of tinea corporis: a pilot study.
    Nuijten ST; Schuller JL
    Rev Infect Dis; 1987; 9 Suppl 1():S119-20. PubMed ID: 3027835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of dermatophytoses and pityriasis versicolor with itraconazole.
    Panconesi E; Difonzo E
    Rev Infect Dis; 1987; 9 Suppl 1():S109-13. PubMed ID: 3027833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N; Phuphaibool K
    J Med Assoc Thai; 1992 Feb; 75(2):99-103. PubMed ID: 1322949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of
    Khurana A; Masih A; Chowdhary A; Sardana K; Borker S; Gupta A; Gautam RK; Sharma PK; Jain D
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Itraconazole in the treatment of tinea capitis.
    Legendre R; Esola-Macre J
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):559-60. PubMed ID: 2170474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis.
    Hay RJ; Clayton YM; Griffiths WA; Dowd PM
    Br J Dermatol; 1985 Jun; 112(6):691-6. PubMed ID: 3890924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Itraconazole in onychomycosis. Open and double-blind studies.
    Walsøe I; Stangerup M; Svejgaard E
    Acta Derm Venereol; 1990; 70(2):137-40. PubMed ID: 1969198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itraconazole in the treatment of human mycoses: review of three years of clinical experience.
    Cauwenbergh G; De Doncker P; Stoops K; De Dier AM; Goyvaerts H; Schuermans V
    Rev Infect Dis; 1987; 9 Suppl 1():S146-52. PubMed ID: 3027842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double blind study of ketoconazole and griseofulvin in dermatophytoses.
    Martínez-Roig A; Torres-Rodríguez JM; Bartlett-Coma A
    Pediatr Infect Dis J; 1988 Jan; 7(1):37-40. PubMed ID: 3277154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo.
    Roseeuw D; Willemsen M; Kint RT; Peremans W; Mertens RL; Van Cutsem J
    Clin Exp Dermatol; 1990 Mar; 15(2):101-4. PubMed ID: 2161302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personal hygiene as an alternative to griseofulvin in the treatment of tinea cruris.
    Akinwale SO
    Afr J Med Med Sci; 2000 Mar; 29(1):41-3. PubMed ID: 11379466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current treatment recommendations in tinea corporis?].
    Tietz HJ
    Med Monatsschr Pharm; 2006 Jul; 29(7):264-5. PubMed ID: 16866081
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.